DK1401501T3 - Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens - Google Patents

Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens

Info

Publication number
DK1401501T3
DK1401501T3 DK02747410T DK02747410T DK1401501T3 DK 1401501 T3 DK1401501 T3 DK 1401501T3 DK 02747410 T DK02747410 T DK 02747410T DK 02747410 T DK02747410 T DK 02747410T DK 1401501 T3 DK1401501 T3 DK 1401501T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
oral pharmaceutical
active ingredient
modified release
modified
Prior art date
Application number
DK02747410T
Other languages
Danish (da)
English (en)
Inventor
Maria Gabriella Massironi
Original Assignee
Farmatron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmatron Ltd filed Critical Farmatron Ltd
Application granted granted Critical
Publication of DK1401501T3 publication Critical patent/DK1401501T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02747410T 2001-06-26 2002-06-19 Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens DK1401501T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI001337A ITMI20011337A1 (it) 2001-06-26 2001-06-26 Composizioni farmaceutiche orali a rilascio modificato del principio attivo

Publications (1)

Publication Number Publication Date
DK1401501T3 true DK1401501T3 (da) 2006-01-09

Family

ID=11447930

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02747410T DK1401501T3 (da) 2001-06-26 2002-06-19 Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens

Country Status (11)

Country Link
US (1) US7727551B2 (fr)
EP (1) EP1401501B1 (fr)
JP (1) JP4657601B2 (fr)
AT (1) ATE302616T1 (fr)
CA (1) CA2451379C (fr)
DE (1) DE60205749T2 (fr)
DK (1) DK1401501T3 (fr)
ES (1) ES2248576T3 (fr)
IT (1) ITMI20011337A1 (fr)
PT (1) PT1401501E (fr)
WO (1) WO2003002151A1 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
WO2003103634A1 (fr) * 2002-06-07 2003-12-18 Ranbaxy Laboratories Limited Formes posologiques orales a liberation prolongee de gabapentine
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
EP1510208A1 (fr) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Compositions pharmaceutiques comprenant une combinaison de metformine et de statine
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
KR20060109922A (ko) * 2003-10-31 2006-10-23 알자 코포레이션 가바펜틴 및 프리가발린의 개선된 흡수를 위한 조성물 및제형
ITMI20032399A1 (it) 2003-12-09 2005-06-10 Zambon Spa Composizione farmaceutica contenente gabapentina.
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
AU2005305880B2 (en) * 2004-11-17 2010-08-26 Ares Trading S.A. Benzothiazole formulations and use thereof
UY29445A1 (es) * 2005-03-30 2006-10-02 Generex Pharm Inc Composiciones para la transmisión transmucosa oral de la metformina
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
ES2288117B1 (es) * 2006-05-08 2008-12-01 Combino Pharm, S.L. Composicion farmaceutica solida de gabapentina.
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
CA2638240C (fr) * 2008-08-29 2010-02-02 Alexander Macgregor Methode de traitement des anomalies de la glycemie et des variations de la glycemie
EP2419085A4 (fr) * 2009-04-14 2013-04-24 Univ California Dispositifs améliorés pour médicaments à usage oral et formulations médicamenteuses
CN102470106B (zh) 2009-05-18 2015-09-23 希格默伊德药业有限公司 包含油滴的组合物
CN101703486B (zh) * 2009-11-24 2011-11-09 上海复旦复华药业有限公司 一种氟他胺片剂及其制备方法
US8581001B2 (en) 2010-04-16 2013-11-12 Codman & Shurtleff Metformin-cysteine prodrug
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN102119931B (zh) * 2011-02-21 2013-02-13 寿光富康制药有限公司 一种盐酸二甲双胍缓释片及其制备方法
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
JP6210640B2 (ja) * 2014-06-19 2017-10-11 大原薬品工業株式会社 ホリナートカルシウム含有錠
ES2858517T3 (es) 2014-11-07 2021-09-30 Sublimity Therapeutics Ltd Composiciones que comprenden ciclosporina
GB201511284D0 (en) * 2015-06-26 2015-08-12 Univ Witwatersrand Jhb An oral pharmaceutical dosage form for the delivery of a peptide and/or protein
JP2017210493A (ja) * 2017-09-08 2017-11-30 大原薬品工業株式会社 ホリナートカルシウム含有錠
IT201800011120A1 (it) 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati
JP2021036003A (ja) * 2020-12-05 2021-03-04 大原薬品工業株式会社 ホリナートカルシウム含有錠
CN117363320B (zh) * 2023-12-07 2024-02-13 黑龙江省鑫博鑫交通科技有限公司 一种公路用融雪剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
TW209174B (fr) 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JPH08283146A (ja) * 1995-10-23 1996-10-29 Boehringer Mannheim Gmbh 成形され、圧縮された徐放性単位投薬形態の調製法およびこうして得られた圧縮単位投薬形態
ES2191977T3 (es) * 1997-10-27 2003-09-16 Merck Patent Gmbh Soluciones y dispersiones en estado solido de farmacos poco solubles en agua.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
ATE251449T1 (de) * 1999-06-14 2003-10-15 Cosmo Spa Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe

Also Published As

Publication number Publication date
EP1401501B1 (fr) 2005-08-24
DE60205749D1 (de) 2005-09-29
WO2003002151A1 (fr) 2003-01-09
DE60205749T2 (de) 2006-03-09
US20040213844A1 (en) 2004-10-28
PT1401501E (pt) 2005-10-31
ITMI20011337A0 (it) 2001-06-26
ITMI20011337A1 (it) 2002-12-26
JP4657601B2 (ja) 2011-03-23
CA2451379A1 (fr) 2003-01-09
EP1401501A1 (fr) 2004-03-31
US7727551B2 (en) 2010-06-01
ATE302616T1 (de) 2005-09-15
JP2004534833A (ja) 2004-11-18
ES2248576T3 (es) 2006-03-16
CA2451379C (fr) 2010-04-06

Similar Documents

Publication Publication Date Title
DK1401501T3 (da) Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens
DK1448235T3 (da) Orale, farmaceutiske sammensætninger af 5,8,14-triaza-tetracyclo[10.3.1.0(2,11).0(4.9)]-hexadeca-2(11),3,5,7,9-pentaen med kontrolleret frigivelse
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
ATE296619T1 (de) Feste orale dosierungsform von simethicon
TR200103575T2 (tr) Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
BR0212922A (pt) Composições farmacêuticas
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
NO20024891L (no) Farmasöytiske sammensetninger
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
CY1109711T1 (el) Νεα κρυσταλλικη μορφη υδροχλωριουχου λερκανιδιπινης και διαδικασιες για την παρασκευη τους
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
IS8051A (is) Kladríbínefnablöndur til inngjafar um munn
ATE392889T1 (de) Orale antimikrobielle pharmazeutische zusammensetzungen
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
NO20064808L (no) Orale matrixformuleringer med licarbazepin
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
EA201101119A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
DK1957037T3 (da) Farmaceutisk præparat til nasal anvendelse af fentanyl
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
DK1648440T3 (da) Halvfaste formuleringer til den orale indgivelse af taxoider
BR0210632A (pt) Tratamento de doença parasìtica
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose